Our research partners

EURIPRED's research partners are mainly based in Europe, but also excellent groups from China, Russia and Kenya join the project. They include the following organisations:

  1. National Institute of Biological Standards and Control, a centre of the Medicines and Healthcare products Regulatory Agency (NIBSC-MHRA), United Kingdom: Dr Mei Mei Ho and Sarah Gilbert
  2. King’s College London, United Kingdom, Dr John Cason and Dr Anna Vyakarnam
  3. National center for AIDS/STD control and prevention, Chinese center for disease control and prevention (NCAIDS), China, Dr Yiming Shao and Dr Liying Ma
  4. D.I. Ivanovsky Institute of virology of the ministry of health and social development of the Russian Federation, Dr Eduard Karamov
  5. Instituto de Salud Carlos III, Spain, Dr Lucía Pérez Álvarez
  6. Kenya Medical Research Institute (KEMRI), Kenya, Dr Steve Wandiga
  7. JPT Peptide Technologies GmbH, Germany, Dr Paul von Hoegen
  8. Polymun Scientific Immunbiologische Forschung GmbH, Austria, Dr Dietmar Katinger
  9. Leiden University and Medical Centre (LUMC), The Netherlands, Prof. Tom Ottenhoff
  10. Icosagen AS, Estonia, Dr Andres Tover
  11. Tuberculosis Vaccine Initiative (TBVI), The Netherlands, Daniëlle Roordink
  12. University of Lausanne (UNIL), Switzerland, Dr. maria Lawrenz and Dr Christophe Barnier-Quer
  13. Lionex GmbH, Germany, Dr Mahavir Singh
  14. University of Oxford, United Kingdom, Prof. Helen McShane
  15. London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom, Prof. Hazel Dockrell and Dr Steven Smith
  16. Eatris, The Netherlands, Dr Giovanni Migliaccio and Florence Bietrix
  17. Federal state budgetary educational institution of higher professional education state university of management, Russian Federation, Dr Fernando Melo and Dr Valery Maslennikov.



Free services »

Reference reagents / adjuvant & formulation studies / microarray facility



Dr Mei Mei Ho
Project coordinator
+44 (0) 1707 641473